ecancer

Dosing regiment in the combination of ipilimumab and nivolumab in stage III melanoma

Dr Lisette Rozeman - Netherlands Cancer Institute, Amsterdam, Netherlands

29 Oct 2018

COLUMBUS: Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma

Prof Dirk Schadendorf - Uniklinik Essen, Essen, Germany

29 Oct 2018

Modern melanoma treatment in the UK

Dr Joseph Sacco - University of Liverpool, Liverpool, UK

26 Oct 2018

KEYNOTE022: Triplet therapy for BRAF melanoma

Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale", Milan, Italy

22 Oct 2018

ESMO 2018: Melanoma highlights

Dr Teresa Amaral, Will Davies

22 Oct 2018

Use of T-VEC in early metastatic melanoma

Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands

21 Oct 2018

Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma

Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA

21 Oct 2018

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

4 Jul 2018

EHA 2018: The unmet needs in maintenance therapy for multiple myeloma

Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng

15 Jun 2018

Updates in melanoma from ASCO 2018

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands

4 Jun 2018

Editor’s Choice for May 2018

Prof Gordon McVie - Founding Editor, ecancer

21 May 2018

Reducing recurrence of advanced melanoma with pembrolizumab

Prof Alex Eggermont - Paris-Sud University, Paris, France

25 Apr 2018

More from ecancer